FDA Pharmacoeconomic Standard Recognizes Cost Of Substantiation - PhRMA
Executive Summary
The standard for substantiation of pharmacoeconomic claims established by the FDA Modernization Act of 1997 allows the agency to consider the economic feasibility of proving the claim, the Pharmaceutical Research & Manufacturers of America maintained in June 22 comments to the agency.